Medication info
Famopan ODT 20 mg (Famotidine)

Famopan ODT 20 mg (Famotidine)

Prescription medicationOrally disintegrating TabletOral
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Korea Pharma Bio Co., Ltd.
Appearance
White round orally disintegrating tablet
Packaging
PTP - 10 tablets/box [10 tablets x PTP], PTP - 100 tablets/box [10 tablets x 10 PTP], Bottle - 100 tablets/bottle [100 tablets/bottle]
Approval status
Active

MFDS item code 202202238 · Approved 2022.05.24 · Insurance code 659901730

Summary

Main use
Improvement of acid-related disorders (including ulcers and gastroesophageal reflux disease), upper gastrointestinal bleeding, and gastric mucosal lesions
Who takes it
Adults
Adult dose
Gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or hemorrhagic gastritis), reflux esophagitis, Zollinger-Ellison syndrome: The usual adult oral dose is 20mg of famotidine twice daily (after breakfast and dinner, or at bedtime). Alternatively, 40mg may be administered orally once daily (at bedtime). The dose may be adjusted appropriately according to age and symptoms. However, in cases of upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation, and switched to oral administration once the patient is able to take medication by mouth. Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis: The usual adult oral dose is 10mg of famotidine twice daily (after breakfast and dinner, or at bedtime). Alternatively, 20mg may be administered orally once daily (at bedtime). The dose may be adjusted appropriately according to age and symptoms. Administration to patients with impaired renal function: Famotidine is excreted mainly unchanged by the kidneys. When famotidine is administered to patients with impaired renal function, the plasma concentration of unchanged drug increases and urinary excretion decreases as renal function declines. Refer to the following dosage regimens. <Based on a dosage of 20mg twice daily> Ccr ≥ 60 20mg per dose, twice daily 60 > Ccr > 30 20mg per dose, once daily 10mg per dose, twice daily 30 ≥ Ccr 20mg per dose, once every 2~3 days 10mg per dose, once daily Patients on dialysis 20mg per dose, once after dialysis 10mg per dose, once daily

Ingredients

Manufacturer
Korea Pharma Bio Co., Ltd.

Efficacy & effects

Improvement of acid-related disorders (including ulcers and gastroesophageal reflux disease), upper gastrointestinal bleeding, and gastric mucosal lesions

  • Gastric ulcers
  • duodenal ulcers
  • anastomotic ulcers
  • upper gastrointestinal bleeding
  • peptic ulcers
  • acute stress ulcers
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosions
  • bleeding
View approved original text

This medication is used to treat peptic ulcers such as gastric ulcers, duodenal ulcers, and anastomotic ulcers. It is also effective for upper gastrointestinal bleeding (peptic ulcers, acute stress ulcers, hemorrhagic gastritis), gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It helps improve gastric mucosal erosions, bleeding, redness, and swelling during acute exacerbations of acute gastritis or chronic gastritis. In short, this drug restores mucosal damage caused by various gastrointestinal diseases and alleviates symptoms, improving the patient's health.

How to take

Adult dose

Gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or hemorrhagic gastritis), reflux esophagitis, Zollinger-Ellison syndrome: The usual adult oral dose is 20mg of famotidine twice daily (after breakfast and dinner, or at bedtime). Alternatively, 40mg may be administered orally once daily (at bedtime). The dose may be adjusted appropriately according to age and symptoms. However, in cases of upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation, and switched to oral administration once the patient is able to take medication by mouth. Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis: The usual adult oral dose is 10mg of famotidine twice daily (after breakfast and dinner, or at bedtime). Alternatively, 20mg may be administered orally once daily (at bedtime). The dose may be adjusted appropriately according to age and symptoms. Administration to patients with impaired renal function: Famotidine is excreted mainly unchanged by the kidneys. When famotidine is administered to patients with impaired renal function, the plasma concentration of unchanged drug increases and urinary excretion decreases as renal function declines. Refer to the following dosage regimens. <Based on a dosage of 20mg twice daily> Ccr ≥ 60 20mg per dose, twice daily 60 > Ccr > 30 20mg per dose, once daily 10mg per dose, twice daily 30 ≥ Ccr 20mg per dose, once every 2~3 days 10mg per dose, once daily Patients on dialysis 20mg per dose, once after dialysis 10mg per dose, once daily

Precautions

This medicine contains the artificial sweetener aspartame. Aspartame is broken down into phenylalanine in the body, so patients with the genetic disorder phenylketonuria should not take this medicine. The daily intake of aspartame should be regulated to below 40 mg/kg as recommended by the World Health Organization; for a 60 kg adult, care should be taken to not exceed a maximum of 2.4 g per day. Patients with a history of allergic reactions to the components of this medicine or similar types of medications should not take this medicine. Patients with a history of allergies, impaired renal function, heart disease, decreased liver function, and the elderly should use this medicine with caution. In particular, patients with impaired renal function may have increased drug concentration, so the dosage should be reduced or the administration interval should be extended. During the use of this medicine, various serious side effects such as severe allergic reactions, hematologic abnormalities, skin diseases, liver dysfunction, muscle damage, cardiac rhythm abnormalities, consciousness disturbances, kidney inflammation, and pneumonia may occur, so symptoms should be monitored carefully. If unusual symptoms occur, stop taking the medicine immediately and consult with medical personnel. Furthermore, this medicine dissolves in the mouth but is not absorbed through the oral mucosa, so it must be swallowed with saliva or water. Patients undergoing dialysis should be cautious as the effectiveness of calcium supplements may decrease when this medication is used with phosphate binders. This medicine may interact with other drugs. In particular, when taken with certain antifungal agents or some anticancer drugs, the acid secretion inhibitory effect of this medicine may lower the blood concentration of those drugs, so it is crucial to inform medical personnel. The elderly are at risk of increased drug concentration due to decreased renal function, so dosage adjustments or changes in administration intervals may be necessary. Women who are pregnant or may become pregnant should only take this medicine when the benefits outweigh the risks, and breastfeeding women should discontinue nursing as this medicine may pass into breast milk. The safety of this medicine in children has not been fully confirmed, so caution is necessary for use. Finally, this medicine can conceal symptoms of gastric cancer, so it should only be used after confirming that the condition is not gastric cancer.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • shortness of breath
  • generalized erythema
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 89 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • Lyell syndrome
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • rise in serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • seizures
  • generalized convulsion
  • tonic seizure
  • clonic seizure
  • interstitial nephritis
  • acute renal failure
  • rash
  • petechiae
  • abnormal blood tests
  • interstitial pneumonia
  • high fever
  • cough
  • shortness of breath
  • ineffective contraction
  • rash
  • petechiae
  • urticaria
  • facial edema
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • soft stool
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • hypertension
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated AST
  • elevated ALT
  • elevated ALP
  • increased total bilirubin
  • elevated LDH
  • liver dysfunction
  • hepatitis
  • malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • sensory disturbance
  • heaviness
  • reversible confusional state
  • depression
  • dizziness
  • irregular menstruation
  • gynecomastia
  • incontinence
  • arthralgia
  • elevated CK
  • dysgeusia
  • myalgia
  • low back pain
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to prevent air and moisture ingress and should be kept at room temperature between 1 degree and 30 degrees. By storing it this way, the effectiveness of the medicine can be maintained for a long time.

Appearance and packaging

Appearance

White round orally disintegrating tablet

Package unit

PTP - 10 tablets/box [10 tablets x PTP], PTP - 100 tablets/box [10 tablets x 10 PTP], Bottle - 100 tablets/bottle [100 tablets/bottle]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.